Unknown

Dataset Information

0

Structural characterization of free-state and product-state Mycobacterium tuberculosis methionyl-tRNA synthetase reveals an induced-fit ligand-recognition mechanism.


ABSTRACT: Mycobacterium tuberculosis (MTB) caused 10.4 million cases of tuberculosis and 1.7 million deaths in 2016. The incidence of multidrug-resistant and extensively drug-resistant MTB is becoming an increasing threat to public health and the development of novel anti-MTB drugs is urgently needed. Methionyl-tRNA synthetase (MetRS) is considered to be a valuable drug target. However, structural characterization of M. tuberculosis MetRS (MtMetRS) was lacking for decades, thus hampering drug design. Here, two high-resolution crystal structures of MtMetRS are reported: the free-state structure (apo form; 1.9?Å resolution) and a structure with the intermediate product methionyl-adenylate (Met-AMP) bound (2.4?Å resolution). It was found that free-state MtMetRS adopts a previously unseen conformation that has never been observed in other MetRS homologues. The pockets for methionine and AMP are not formed in free-state MtMetRS, suggesting that it is in a nonproductive conformation. Combining these findings suggests that MtMetRS employs an induced-fit mechanism in ligand binding. By comparison with the structure of human cytosolic MetRS, additional pockets specific to MtMetRS that could be used for anti-MTB drug design were located.

SUBMITTER: Wang W 

PROVIDER: S-EPMC6038951 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural characterization of free-state and product-state <i>Mycobacterium tuberculosis</i> methionyl-tRNA synthetase reveals an induced-fit ligand-recognition mechanism.

Wang Wei W   Qin Bo B   Wojdyla Justyna Aleksandra JA   Wang Meitian M   Gao Xiaopan X   Cui Sheng S  

IUCrJ 20180622 Pt 4


<i>Mycobacterium tuberculosis</i> (MTB) caused 10.4 million cases of tuberculosis and 1.7 million deaths in 2016. The incidence of multidrug-resistant and extensively drug-resistant MTB is becoming an increasing threat to public health and the development of novel anti-MTB drugs is urgently needed. Methionyl-tRNA synthetase (MetRS) is considered to be a valuable drug target. However, structural characterization of <i>M. tuberculosis</i> MetRS (MtMetRS) was lacking for decades, thus hampering dru  ...[more]

Similar Datasets

| S-EPMC8136816 | biostudies-literature
| S-EPMC7103878 | biostudies-literature
2020-12-23 | PXD021527 | Pride
| S-EPMC8216282 | biostudies-literature
| S-EPMC4287814 | biostudies-literature
| S-EPMC2286561 | biostudies-literature
| S-EPMC5120670 | biostudies-literature
| S-EPMC6437504 | biostudies-literature